FF
INTC icon

Formulate Financial’s Intel INTC Stock Holding History

Formulate Financial’s Portfolio INTC Stock Details INTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$435K Buy
+3,620
New +$369K 0.45% 19

Other funds holding INTC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Formulate Financial's INTC Position: Q3 2026 in Review

Formulate Financial opened a new position in Intel (INTC) in Q3 2026: 3,620 shares worth $435K. The stake represents 0.45% of the portfolio and ranks #19 among its holdings.

2,441 funds tracked by Wall St. Rank hold INTC as of Q3 2026.

  • Formulate Financial held 3,620 shares of Intel worth $435K as of Q3 2026.
  • Intel was a new Formulate Financial position in Q3 2026.
  • Intel made up 0.45% of Formulate Financial's portfolio in Q3 2026, its #19 holding.
  • 2,441 funds tracked by Wall St. Rank held Intel as of Q3 2026.

Based on Formulate Financial's 13F filing for Q3 2026, filed 9 Nov 2026.